Advertisement
News
Advertisement

Allegro Diagnostics rounds up $5.4M Series A funding

Thu, 07/07/2011 - 5:35am
Mass High Tech: The Journal of New England Technology

Allegro Diagnostics Inc., a Maynard developer of medical tests for cancer, has closed a $5.4 million Series A financing round, backed by Kodiak Venture Partners and Catalyst Health Ventures. The funding will be used to move the company’s BronchoGen genomic test, used to detect potential lung cancer signs, into commercialization next year.

The company’s testing platform is made to notice molecular response in a respiratory tract and note any sign of malignant airway cells in the lungs.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading